Yichang Hec Changjiang Pharmaceutical Co. Ltd. has announced the results of the exercise of the right of dissenting shareholders in relation to an ongoing transaction. The company, in conjunction with Sunshine Lake Pharma Co., Ltd., released a joint announcement to provide updates on the matter. The board of Yichang Hec Changjiang, led by Chairman Tang Xinfa, confirmed that the directors jointly take full responsibility for the accuracy of the information provided in the announcement, ensuring that all opinions expressed have been arrived at after due and careful consideration. The update follows previous communications regarding the transaction, aiming to keep stakeholders informed about the latest developments.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yichang Hec Changjiang Pharmaceutical Co. Ltd. published the original content used to generate this news brief on July 23, 2025, and is solely responsible for the information contained therein.